On Oct.10, Chengdu Tianfu Global International Biocity saw the signing of ten 
project agreements totalling nearly 9B CNY in value and covering modern 
biopharmaceuticals, innovative chemical drugs, sophisticated medical 
apparatuses and other important fields. 

Geneseeq, a Chinese genetic disease testing giant, intends to invest in a local 
facility and industrialization base of genetic infection and tumor diagnosis as 
southwestern China-based its headquarters. They're devoted to becoming 
Geneseeq's second head office in China as well as the pacesetter of testing & 
diagnosis in midwestern China.

Shanghai Siyi Intelligent Technology Co., Ltd., a leading Chinese soft robotics 
manufacturer, will build a rehabilitation platform that integrates the 
hospital, community and family. At the same time, Siyi will locate its 
operating head office, listed company office and manufacturing facility to 
Tianfu International Biocity.

"Tianfu International Biocity helps us with both investment and subsidy to 
support the projects and solve investment and financing problems. From the 
perspective of upstream and downstream analysis, improve the industry chain and 
save us a lot time in upstream-downstream communication," said Yin Ganggang, 
founder of Siyi.    

"The signing of these agreements will make bioindustrial innovation 
transformation. In the future, the biocity will continue to build more project 
clusters that consistently gain in magnitude and promote the industry of 
pharmaceuticals," said the spokesman of Chengdu Tianfu International Biocity.   

Commenced in March 2016 and located in southwestern Shuangliu (part of Chengdu, 
the capital of Sichuan), Chengdu Tianfu International Biocity has a planned 
area of around 44 square kilometers. The Biocity includes five industries, i.e. 
biopharmaceuticals, innovative chemical drugs, high-performance medical 
equipment, professional outsourcing service and health service. These 
industries are intended to promote the close combination of the industry chain, 
innovation chain and supply chain, therefore adding to the local driving force 
and competitiveness of the modern industry. 

Since foundation, Tianfu International Biocity has seen its bioindustry gain in 
economic contribution and competitiveness. The first-phase 9-km city framework 
is already in place. 

In order to attract investments from biopharmaceutical professionals, Chengdu 
Tianfu International Ecocity attaches importance to urban livability, constant 
improvements in urban functions, worker-inhabitant balance improvement and life 
convenience in order to meet the residential requirements of local people and 
company employees. Yong'an Lake Urban Forest Park, Incubator Shopping Street, 
community complexes and other business models are contributing step by step to 
such consumer markets as food, hospitality, travel, tourism, shopping and 
recreation. Now, Chengdu Tianfu International Biocity is on its way to becoming 
a global base of innovative biopharmaceuticals. 

Source: Chengdu Tianfu Global International Biocity